Published in:
25-01-2024 | Artificial Intelligence | Original Articles
Complications Following Body Contouring: Performance Validation of Bard, a Novel AI Large Language Model, in Triaging and Managing Postoperative Patient Concerns
Published in: Aesthetic Plastic Surgery | Issue 5/2024
Login to get accessAbstract
Introduction
Large language models (LLM) have revolutionized the way humans interact with artificial intelligence (AI) technology, with marked potential for applications in esthetic surgery. The present study evaluates the performance of Bard, a novel LLM, in identifying and managing postoperative patient concerns for complications following body contouring surgery.
Methods
The American Society of Plastic Surgeons’ website was queried to identify and simulate all potential postoperative complications following body contouring across different acuities and severity. Bard’s accuracy was assessed in providing a differential diagnosis, soliciting a history, suggesting a most-likely diagnosis, appropriate disposition, treatments/interventions to begin from home, and red-flag signs/symptoms indicating deterioration, or requiring urgent emergency department (ED) presentation.
Results
Twenty-two simulated body contouring complications were examined. Overall, Bard demonstrated a 59% accuracy in listing relevant diagnoses on its differentials, with a 52% incidence of incorrect or misleading diagnoses. Following history-taking, Bard demonstrated an overall accuracy of 44% in identifying the most-likely diagnosis, and a 55% accuracy in suggesting the indicated medical dispositions. Helpful treatments/interventions to begin from home were suggested with a 40% accuracy, whereas red-flag signs/symptoms, indicating deterioration, were shared with a 48% accuracy. A detailed analysis of performance, stratified according to latency of postoperative presentation (<48hours, 48hours–1month, or >1month postoperatively), and according to acuity and indicated medical disposition, is presented herein.
Conclusions
Despite promising potential of LLMs and AI in healthcare-related applications, Bard’s performance in the present study significantly falls short of accepted clinical standards, thus indicating a need for further research and development prior to adoption.
Level of Evidence IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.